REGENXBIO Completes Enrollment in Landmark Trials for Vision Loss Treatment REGENXBIO Inc. has wrapped up participant enrollment in pivotal studies for its gene therapy aimed at treating wet AMD. This marks a significant step in fighting vision loss globally.

REGENXBIO Completes Enrollment in Landmark Trials for Vision Loss Treatment #United_States #Wet_AMD #Rockville #REGENXBIO #surabgene